SSTI Digest

Using data from its 2004 Best Performing Cities Index, Milken has generated a comprehensive table ranking cities by one- and five-year measurements of job growth, wages and salaries, and relative high tech gross domestic product (GDP) growth, and other measurements.

SSTI would like to draw readers' attention to one of those other measurements, Milken's high-tech GDP location quotient (LQ), which may be of some value to the tech-based economic development community. LQ is defined as a measure of high-tech concentration, with the U.S. given a value of 1.0. For the Milken study, metro areas having an LQ higher than 1.0 are said to be more concentrated in high tech sectors than the U.S.

What policies, investments and programs would be most effective for communities trying to attract, retain or build a local pharmaceutical industry? Research parks? Tax incentives? Biotech seed capital funds?

The answers one gets will vary, but using historical data on patent activity and observing the location of the largest pharmaceutical companies, a group of researchers suggests investments in academic R&D that lead to publications is not a bad place to start.

Duane Roth is the new executive director of UCSD CONNECT. Roth was CEO of Alliance Pharmaceuticals in San Diego.

While the National Institutes of Health (NIH) and the National Science Foundation (NSF) have voiced caution and funded efforts to understand the potential societal and environmental implications of nanotechnology deployment, both agencies announced much larger funding commitments - totaling $213 million - to expedite commercial applications for the explosive field.

Nanotech Solutions for Cancer Carrying a federal five-year price tag of $144.3 million, the NIH's National Cancer Institute (NCI) is forming the NCI Alliance for Nanotechnology in Cancer, a comprehensive, integrated initiative encompassing researchers, clinicians, and public and private organizations that have joined forces to develop and translate cancer-related nanotechnology research into clinical practice.

More than half since recession "officially" ended There is little comforting news in a new statistical report for workers in the U.S. information and communication technologies (ICT) sector. Researchers from the University of Illinois-Chicago found the sector lost 403,300 jobs between March 2001 and April 2004.

A staggering 200,000 of the high-wage jobs were lost since the recession was officially declared over in November 2001, making the notion of a jobless recovery a significant understatement for the sector.

The resilience of the regional ICT sectors and the overall economies of the seven profiled metropolitan areas are being tested with the incredible losses suffered since the bubble burst in March 2001. The following list presents the percentage change in total ICT employment between March 2001 and April 2004 for the seven primary metropolitan statistical areas (PMSA):

As part of a new initiative to address pressing ethical, legal and social questions raised by recent advances in genetic and genomic research, the National Human Genome Research Institute (NHGRI) has awarded approximately $20 million in grants to fund interdisciplinary centers within universities around the country over the next five years. NHGRI is one of the National Institutes of Health (NIH).

According to NIH, each of the centers will assemble a team of experts in several disciplines such as bioethics, law, behavioral and social sciences, clinical research, theology, public policy and genetic and genomic research to develop innovative research approaches focused on specific sets of issues related to genomic research. The centers’ output, according to NIH, will be critical in formulating and implementing effective and equitable health and social polices related to genomic research.

New York City Launches Second Biotech Incubator Companies wanting to commercialize new technologies can now bring their companies to Brooklyn, with the June opening of a new technology incubator located near Downstate University's biochemistry department. The Advanced Biotechnology Incubator will eventually house up to 30 companies, according to Eva Brown Cramer, vice president for biotechnology and scientific affairs at Downstate. The $12 million incubator, funded by both government and private sources, is a first for Brooklyn and second to be opened in New York City. The first was opened in 1995 at Columbia University, according to the Daily News. Colorado Incubator Merges With Venture Company, Becomes CTEK

The National Institutes of Health (NIH), the largest federal funding source for life sciences research conducted by small tech firms, has selected the Larta Institute to manage its nationwide Commercialization Assistance Program. The multi-year $2.5 million award will target Phase II recipients of the NIH Small Business Innovation Research and Small Business Technology Transfer Programs (SBIR/STTR).

"NIH is interested in seeing products derived from SBIR funding make their way into the marketplace for the benefit of the American people," said Jo Anne Goodnight, NIH SBIR/STTR Program Coordinator. "We are committed not only to supporting high quality research through NIH SBIR awards, but to investing in the long-term success of our SBIR-winners."

The U.S. Department of Labor (DOL) launched last month a $17.2 million national Biotechnology Worker Training Initiative in support of the President’s High Growth Job Training Initiative.

“This $17.2 million in training funds will recruit and train workers for jobs in the biotechnology field, which is expected to be one of the fastest growing sectors by 2012,” said Secretary of Labor Elaine Chao.

An initial award of $2.4 million was made to the Pittsburgh Life Sciences Greenhouse (PLSG), a public-private partnership dedicated to Western Pennsylvania's life sciences industry. Chao said the grant to PLSG would help increase awareness about promising biotech-related careers in the state, while addressing the need for skilled workers.

The U.S. Department of Commerce and the National Academy of Public Administration (NAPA) recently released reports making recommendations to address the challenges faced by the manufacturing industry. One of the recommendations in the NAPA report suggests creating a strategic plan that articulates the "next generation" of the Commerce Department's National Institute of Standards and Technology (NIST) Manufacturing Extension Partnership (MEP). To gather public comment on the strategic plan and respond to both reports' recommendations, MEP will hold a series of regional roundtables and webcasts this summer:

Although a significant gap still exists between women-led companies and their male counterparts, in terms of venture funding, some promising news may suggest a change in fortune for the former, a study released today by Growthink Research of Los Angeles and Chicago-based re:invention Inc. shows.

The 400-page study, Venture Funding for Women Entrepreneurs, provides a detailed profile of women-led, venture capital (VC)-funded, privately-held business enterprises and companies with women executives. The report is based on a comprehensive analysis of 1,860 companies that raised more than $19 billion of venture capital in 2003.

California voters will be at the forefront of a highly controversial issue this November when they are asked to decide on a $3 billion bond issue to fund stem cell research.

The initiative, if passed, would provide $295 million annually to California researchers over the next 10 years. Under the proposal, priority for funding would be given to stem cell research that does not qualify for federal funding, and up to 10 percent could be used to build research facilities for nonprofit research organizations.